Treatment with hydrogen molecules prevents RANKL-induced osteoclast differentiation associated with inhibition of ROS formation and inactivation of MAPK, AKT and NF-kappa B pathways in murine RAW264.7 cells.
J Bone Miner Metab. 2014 Sep;32(5):494-504. doi: 10.1007/s00774-013-0530-1. Epub 2013 Nov 7.
J Bone Miner Metab. 2014.
PMID: 24196871